Gene therapy for sickle cell disease passes key preclinical test

A precision-engineered gene therapy virus, inserted into blood stem cells that are then transplanted, markedly reduced sickle-induced red-cell damage in mice with sickle cell disease, researchers from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center reported in the Journal of Clinical Investigation.

Transitioning to adult care for sickle cell disease: Ariyanna's journey - Boston Children's Answers

Transitioning to adult care for sickle cell disease: Ariyanna's journey - Boston Children's Answers

Rectal Bleeding (Blood in Stool): Causes, Colors & Treatments

HemaApp screens for anemia, blood conditions without needle sticks

Health Archives — Page 34 of 107 — Harvard Gazette

Milwaukee Area Sickle Cell Support Group

sickle cell disease Archives - Page 2 of 2 - Boston Children's Answers

Sickle cell gene therapy passes key preclinical test - Boston Children's Answers

News & Events - latest news and happenings in the SCD community

Milwaukee Area Sickle Cell Support Group

Sickle cell disease: MedlinePlus Genetics

Solved What is a theoretical number of hemoglobin molecules

Gene therapy for sickle cell disease passes key preclinical test — Harvard Gazette

St. Jude Research on X: People with sickle cell disease have red blood cells that contain mostly hemoglobin S, which causes the red blood cells to change from a round circle shape

Hemoglobin & Myoglobin: 4. Dissociation Curves - Biochemistry Flashcards